Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer

Clinical and Experimental Metastasis

Volumn 24, Issue 2, 2007, Pages 121-130

  Bailey, Charles ^a,b   Negus, Rupert ^a   Morris, Alistair ^a   Ziprin, Paul ^a   Goldin, Robert ^a   Allavena, Paola ^c   Peck, David ^a   Darzi, Ara ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

CCL2 (MCP 1); Chemokine; Colon cancer; CXCL8 (IL 8); Cytokine; Leukocyte; Rectal cancer; Tumour associated macrophage (TAM)

Indexed keywords

INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER IMMUNOLOGY; CELL INFILTRATION; CELLULAR DISTRIBUTION; COLON ADENOCARCINOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; NEUTROPHIL CHEMOTAXIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RIBONUCLEASE PROTECTION ASSAY; SUPERNATANT;

CELL LINE, TUMOR; CHEMOKINES; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; RNA, MESSENGER;

EID: 34247576326     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10585-007-9060-3     Document Type: Article

References (40)

1. IUS/WHO subcommittee on chemokine nomenclature (2002) Chemokine/chemokine receptor nomenclature. J Interferon Cytokine Res 22:1067-1068
2. Rossi D, Zlotnik A (2000) The biology of chemokines and their receptors. Annu Rev Immunol 18:217-242
3. Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12:121-127
4. Larsen CG, Anderson AO, Appella E et al (1989) The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 243:1464-1466
5. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539-545
6. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860-867
7. Balkwill F (2003) Chemokine biology in cancer. Semin Immunol 15:49-55
8. Burke F, Relf MG, Negus RPM et al (1996) A cytokine profile of normal and malignant ovary. Cytokine 8:578-585
9. Rollins BJ (2006) Inflammatory chemokines in cancer growth and progression. Eur J Cancer 42:760-767
10. Negus RPM, Stamp GWH, Relf MG et al (1995) The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest 95:2391-2396
11. Luboshits G, Shina S, Kaplan O et al (1999) Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res 59:4681-4687
12. Saji H, Koike M, Yamori T et al (2001) Significant correlation of monocyte chemoattractant protein-1 expression with neovascularisation and progression of breast carcinoma. Cancer 92:1085-1091
13. Negus RPM, Stamp GWH, Hadley J, Balkwill FR (1997) A quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am J Pathol 150:1723-1734
14. Ueno T, Toi M, Saji H, Muta M et al (2000). Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 6:3282-3289
15. Mantovani A, Bottazi B, Colotta F et al (1992) The origin and function of tumour-associated macrophages. Immunol Today 13:265-270
16. Mantovani A, Ming WA, Balotta C, Abdeljalil B et al (1986) Origin and regulation of tumor-associated macrophages: the role of tumor-derived chemotactic factor. Biochem Biophys Acta 865:59-67
17. Barbera-Guillem E, Nyhus J.K, Wolford CC et al (2002) Vascular endothelial growth factor secretion by tumour-infiltrating macrophages essentially supports tumour angiogenesis, and IgG immune complexes potentiate the process. Cancer Res 62:7042-7049
18. Lewis CE, Pollard JW (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res 66:605-612
19. Sica A, Schioppa T, Mantovani A et al (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42:717-727
20. Rollins BJ (1997) Chemokines. Blood 90:909-928
21. Tsuchiya S, Yamabe M, Yamaguchi Y et al (1980) Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 26:171-176
22. Curtis ASG (1960) Area and volume measurements by random sampling methods. Med Biol Illus 10:261-266
23. Dehoff RT, Rhines FN (1961) Determination of the number of particles per unit volume from measurements made on random plane sections: the general cylinder and ellipsoid. Trans Am Inst Mining Metallurg Eng 221: 975
24. Aherne WA, Dunhill MS (1982) Morphometry. Arnold, London
25. Kolios G, Wright K, Jordan N et al (1999) C-X-C and C-C chemokine expression and secretion by the human colonic epithelial cell line, HT-29: differential effect of T lymphocyte-derived cytokines. Eur J Immunol 29:530-536
26. Banner BF, Savas L, Baker S et al (1993). Characterization of the inflammatory cell populations in normal colon and colonic carcinomas. Virchows Arch B Cell Pathol 64:213-220
27. Fidler IJ, Schroit AJ (1984) Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases. J Immunol 133:515-518
28. Mantovani A (1994) Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab Invest 71:5-16
29. Huang S, Van Arsdall M, Tedjarati S et al (2002) Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst 94:1134-1142
30. Bingle L, Lewis CE, Corke K et al (2006) Macrophages promote angiogenesis in human breast tumour spheroids in vivo. Br J Cancer 94:101-107
31. Tsutsui S, Yasuda K, Suzuki K et al (2005) Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep 14:425-431
32. Ohno S, Ohno Y, Suzuki N et al (2004) Correlation of histological localization of tumour-associated macrophages with clinicopathological features in endometrial cancer. Anticancer Res 24:3335-3342
33. Hanada T, Nakagawa M, Emoto A et al (2000) Prognostic value of tumour-associated macrophage count in human bladder cancer. Int J Urol 7:263-269
34. + T cell and macrophage peritumoral infiltration in colorectal cancer. Oncol Rep 10:309-313
35. Negus RP, Turner L, Burke F et al (1998) Hypoxia down-regulates MCP-1 expression: implications for macrophage distribution in tumours. J Leukoc Biol 63:758-765
36. Salcedo R, Ponce ML, Young HA et al (2000) Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumour progression. Blood 96:34-40
37. Scotton CJ, Wilson JL, Milliken D et al (2001) Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res 61:4961-4965
38. Brew R, Erikson JS, West DC et al (2000) Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 12:78-85
39. Ueda T, Shimada E, Urakawa T (1994) Serum levels of cytokines in patients with colorectal cancer: possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis. J Gastroenterol 29:423-429
40. Griffiths L, Binley K, Iqball S et al (2000) The macrophage - a novel system to deliver gene therapy to pathological hypoxia. Gene Ther 7:255-262